3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Colorectal Neoplasms
22
Neoplasms
13
Colonic Neoplasms
10
Breast Neoplasms
10
Venous Thromboembolism
8
Prostatic Neoplasms
8
Multiple Myeloma
7
Recurrence
6
Polycythemia Vera
6
Carcinoma, Non-Small-Cell Lung
6
Thrombocythemia, Essential
4
Neoplasms, Plasma Cell
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Thrombosis
2
Sarcoma
2
Rectal Neoplasms
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Myocardial Infarction
2
Lung Neoplasms
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammation
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Interventions
Tranexamic Acid
12
Sodium Chloride
4
Misoprostol
4
Saline Solution
3
carbetocin
2
Tourniquets
2
Oxytocin
2
Enoxaparin
2
Endoscopic Mucosal Resection
2
Dalteparin
2
Vitamin B 6
1
Vasopressins
1
Uterine Artery Embolization
1
Ultrasonography
1
Tinzaparin
1
Thoracic Surgery, Video-Assisted
1
Terlipressin
1
Sutures
1
Surveys and Questionnaires
1
Surgicel
1
Standard of Care
1
Solutions
1
Sensitivity Training Groups
1
Rivaroxaban
1
Ringer's Lactate
1
Radiotherapy
1
Pancreaticoduodenectomy
1
Palliative Care
1
Neuromuscular Blockade
1
N(4)-oleylcytosine arabinoside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hemorrhage
×
Aspirin
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled